A Systematic Analysis of Carbon Capture Technologies: Bridging the Gap Between Theory and Application
Abstract
The increasing concentrations of greenhouse gases, especially carbon dioxide (CO₂), have become a major factor influencing global warming and climate change. As the international community enhances efforts to achieve carbon neutrality in the upcoming decades, carbon capture, utilization, and storage (CCUS) technologies have gained prominence as a key strategy for reducing CO₂ emissions from industrial and energy sectors. This review comprehensively examines the current state of development, emerging research trends, technological obstacles, and innovative approaches in the CCUS field. Among the various CO₂ capture techniques, solvent absorption—particularly through amine-based and ionic liquid solvents—remains the most advanced and commonly utilized method. Ionic liquids present significant potential due to their adaptable molecular structures and lower energy requirements. In solid adsorption, the surface modification of metal-organic frameworks (MOFs) has shown considerable CO₂ adsorption capacity. Moreover, the creation of hybrid capture systems that combine ionic liquids, membranes, and nanomaterials has indicated promise in lowering energy expenses and enhancing efficiency.
The transportation of CO₂, mainly through pipelines, must take into account temperature, pressure, and impurity levels, as these variables affect phase behavior and transport safety. Utilization methods, including enhanced oil and gas recovery, coalbed methane displacement, and the conversion into value-added chemicals—particularly methanol utilizing copper-based catalysts, are also examined. The merging of electrocatalysis with renewable energy is recognized as a future pathway for effective CO₂ conversion. Geological storage, especially in deep saline aquifers, is viewed as the most dependable long-term solution, although concerns regarding reservoir stability and possible leakage remain. Monitoring technologies alongside risk assessments are critical for maintaining environmental safety.
References
1 , Jianping Zhai , Li Lib, , Lihou Dongb , Kelly Dongc , Shensi Xiangb , Luolan Guia,b,c , Jiaying Zhangc , Haifeng Songb, , Zhiqiang Gea, Simultaneous quantitative determination of liraglutide and insulin degludec in rat plasma by liquid chromatography-tandem mass spectrometry method and its application (2020)
4 Max Sauter, Philipp Uhl, Jürgen Burhenne, Walter E. Haefeli. Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLCMS/MS. Journal of Pharmaceutical Analysis (2020) 02.008.
5 Asmaa A. El-Zaher, Hanaa A. Hashem, Ehab F. Elkady, Marwa A. Allam. A validated LC-MS/MS bioanalytical method for the simultaneous determination of dapagliflozin or saxagliptin with metformin in human plasma, Microchemical Journal (2020) 1-8
6 Lydia Rabbaa‐Khabbaz a , Rita Abi Daoud a , Dolla Karam‐Sarkis a , Chawki Atallah b & Antoine Zoghbi b A Simple and Sensitive Method for Determination of Glimepiride in Human Serum by HPLC, (2005) 3255–3263,
7 Sujatha Samala, Sandhya Rani Tatipamula, Ciddi Veeresham Determination of Glimepiride in Rat Serum by RP-HPLC Method American Journal of Analytical Chemistry, 2011, 2, 152-157
8 Ying Hoo Lama , Mei Tik Leungb , Chor Kwan Chinga , Tony Wing Lai Maka. Simultaneous detection of 24 oral antidiabetic drugs and their metabolites in urine by liquid chromatography–tandem mass spectrometry Journal of Chromatography B (2020)
9 Xiuhua Zhang a , Jianshe Ma b , Lufeng Hu a , Qingwei Zhang c , Xianqin Wang d , Jianchun Pan d & Faqing Ye d . SIMULTANEOUS DETERMINATION OF TOLBUTAMIDE AND ITS METABOLITE HYDROXYTOLBUTAMIDE IN RAT PLASMA BY LC-MS.(2012) 1627-1637
10 Shinji Kobuchi Megumi Matsuno Etsuko Fukuda Yukako Ito Toshiyuki Sakaeda. Development and validation of an LC–MS/MS method for the determination of tofogliflozin in plasma and its application to a pharmacokinetic study in rats Journal of Chromatography B (2016) 30374-9
11 Shinji Kobuchi, Kyoka Yano, Yukako Ito and Toshiyuki Sakaeda*A validated LC-MS/MS method for the determination of canagliflozin, a sodium– glucose co-transporter 2 (SGLT-2) inhibitor, in a lower volume of rat plasma: application to pharmacokinetic studies in rats Biomed. Chromatogr. 2016
12 Annemarie B. van der Aart-van der Beek, A. Mireille A. Wessels, Hiddo J.L. Heerspink, Daan J. Touw Simple, fast and robust LC-MS/MS method for the simultaneous quantification of canagliflozin, dapagliflozin and empagliflozin in human plasm Journal of Chromatography B (2020) 30276-2
13Shinji Kobuchi, Yukako Ito, Kyoka Yano, Toshiyuki Sakaeda A quantitative LC–MS/MS method for determining ipragliflozin, a sodium-glucose co-transporter 2 (SGLT-2) inhibitor, and its application to a pharmacokinetic study in rats Journal of Chromatography B (2015) 22-28
14 Gabriel Onn Kit Loha , Emily Yii Ling Wonga , Yvonne Tze Fung Tana , Yi Lin Leeb , Lai Hui Pangb , May Chien Chinb , Nair Damenthib , Kok Khiang Pehc Simple and rapid LC-MS/MS method for determination of sitagliptin in human plasma and application to bioequivalence study. ournal of Chromatography B 1159 (2020) 12233
15. Maha F. Abdel-Ghany, Omar Abdel-Aziz, Miriam F. Ayad, Mariam M. Tadros. Enhanced LC–MS/MS analysis of alogliptin and pioglitazone in human plasma: Applied to a pharmacokinetic Journal of Chromatography B (2016)31408-8
16 Jahidur Rashid, Fakhrul Ahsan. A highly sensitive LC–MS/MS method for concurrent determination of sildenafil and rosiglitazone in rat plasma Journal of Pharmaceutical and Biomedical Analysis s 129 (2016) 21–27
17 Khadiga M. Kelani, Mamdouh R. Rezk, Osama M. Badran, Mohamed R. Elghobashy. Determination of pioglitazone, its metabolite and alogliptin in human plasma by a novel LC-MS/MS method; application to a pharmacokinetic study Journal of Chromatography B (2019)31067-0
18. Xiangjun Qiu1, Shuang-li Zheng2, Yingfei Wang1, Rong Wang1 and Lei Ye3* A Rapid and Simple UPLC–MS-MS Method for Determination of Glipizide in Human Plasma and Its Application to Bioequivalence Study ournal of Chromatographic Science 2015;53:85–89
19. Jie Zhanga , Feng Gaoa , Xin Guana , Yan-tong Suna,b , Jing-kai Gua,n , J. Paul Fawcett. Determination of repaglinide in human plasma by high-performance liquid chromatography–tandem mass spectrometry$ Acta Pharmaceutica Sinica B (2011) 40-45
20. Mohd Aftab Alam , Fahad Ibrahim Al-Jenoobi , and Abdullah Mohammed Al-Mohizea Rapid, Validated UPLC-MS/MS Method for Determination of Glibenclamide in Rat Plasma. International Journal of Analytical Chemistry 2018: 1-08
21. Xiaohui (Sophia) Xua,∗ , Roger Demers b , Huidong Gua , Lisa J. Christopher a , Hong Sua, Laura Cojocarub , David W. Boultona, Mark Kirbya, Bruce Stouffer a, William G. Humphreys a, Mark E. Arnolda Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: Method validation and overcoming specific and non-specific binding at low concentrations journal of Chromatography B, 889–890 (2012) 77–86